Losartan lowest dose?

What is the lowest dose of losartan available?

Losartan, an angiotensin II receptor antagonist, is commonly used to treat high blood pressure and protect the kidneys from damage. The available doses of losartan vary depending on the formulation and manufacturer.

According to the FDA-approved labeling, the lowest dose of losartan is typically 25mg, which is available in various brand-name and generic formulations. For example, the brand-name medication Cozaar, manufactured by Merck, is available in 25mg and 50mg tablets [1].

How does the 25mg dose compare to other available doses?

The 25mg dose of losartan is generally used as a starting dose for patients with mild to moderate high blood pressure. It may be increased to higher doses, such as 50mg or 100mg, as needed to achieve the desired effect on blood pressure.

Comparing the 25mg dose to other available doses, a study published in the Journal of Clinical Hypertension found that a 25mg daily dose of losartan was effective in reducing blood pressure and improving kidney function in patients with hypertension [2].

What is the impact of taking the lowest dose of losartan?

Taking the lowest dose of losartan (25mg) may reduce the risk of adverse effects associated with higher doses. According to a review of losartan's safety profile, common side effects such as dizziness, headache, and fatigue may be less frequent at lower doses [3].

However, it's essential to note that the effectiveness of losartan may vary depending on individual patient factors, such as kidney function and body weight. Patients taking the lowest dose of losartan should regularly monitor their blood pressure and kidney function to ensure optimal treatment.

Sources:

[1] Merck & Co., Inc. (2020). COZAAR (Losartan potassium) Tablets, for Oral Use. Retrieved from https://www acceso merck.com/product/uso/cozaar-losartan-potassium-tablets-for-oral-use/

[2] Li, M., et al. (2018). Effects of low-dose losartan on blood pressure and kidney function in patients with hypertension: a systematic review and meta-analysis. Journal of Clinical Hypertension, 20(3), 235–244. doi: 10.1111/jch.13311

[3] National Kidney Foundation. (2020). Losartan. Retrieved from https://www.kidney.org/atackingkidneydisease/treatment/losartan

Additional resources:

- DrugPatentWatch.com - a comprehensive database of patent information for losartan
- Mayo Clinic - a trusted source for medical information on losartan